Table 2.
Included study reported outcomes
| References | Pain pre/post | Outcome score pre/post | OA progression | Additional treatment | Additional surgery |
|---|---|---|---|---|---|
| Becher et al. [1] | VAS score 6.5 ± 2.3 2.4 ± 2.8** |
HSS (function) 3.6 ± 2.3/7.2 ± 2.8** |
Not given | Not specified | 4/45 8.9% |
| Buda et al. [4] | Not given | AOFAS 52.3 ± 14.2/77.8 ± 18.3 |
15/56 26.8% |
Not specified | 16/56 28.6% |
| Giannini et al. [7] | Not given | AOFAS 26.6 ± 6/77.8 ± 8.7** |
26/26 100% |
3/26 11.5% |
3/26 11.5% |
| Gobbi et al. [9] | Not given | AOFAS 3.8/83.8** 31.1/85.4** |
Not given | 1/21 4.8% |
3/21 14.3% |
| Jeng et al. [10] | AOFAS (post) “success” only: 31 | AOFAS (post) “success” only 84 (71–96) |
6/29 20.7% |
Not specified | 14/29 48.3% |
| Marijnissen et al. [11] | AOS 67.1 ± 15.2/38.2 ± 23.8 |
AOS 68.3 ± 15.1/35.9 ± 23.0 |
Not given | 2/105 1.9% |
16/105 15.2% |
| Nguyen et al. [14] | Not given | AOS 60.7 ± 12.2/34.4 ± 24.0 |
Not given | Not specified | 13/29 44.8% |
| Ploegmakers et al. [16] | Van Valburg 78 ± 3%/30 ± 5%** |
AOS 67 ± 6/25 ± 6* |
Not given | 1/22 4.5% |
5/22 22.7% |
| Saltzman et al. [17] | Not given | AOS 63.14 ± 11.88 (motion) 62.77 ± 13.23 (fixed)/34.64 ± 19.12 (motion) 54.29 ± 21.74 (fixed) |
Not given | Not specified | Not specified |
| Tellisi et al. [21] | AOFAS 15/31 |
AOFAS 55 (29–82)/74 (47–96)* |
2/25 8.0% |
Not specified | 2/25 8.0% |
*p < 0.05; **p < 0.001